Previous Section

• Leukaemia trials

Current Section

• UKALL 2003

• Archive
• New centres: Applying for Site Specific Assessment (PDF)
• UKALL2003 Reg A (PDF)
• UKALL2003 Reg B (PDF)
• UKALL2003 Reg C (PDF)
• Sponsor letter 19th January 2005
• Sponsor letter 11th July 2006
• Annual Report 2006
• Annual Report 2007
• Applying for Site Specific Assessment
• UKALL 2003 Forms
• Trial Registration Form
• Notification of amendment 6MP
• MHRA Approval for amended 6MP suspension IMPD
• Modification of Recommendations for transplantation of patients with iAMP21
• Bristol MRD lab address
• Treatment Modifications for Downs Syndrome Patients
• Leukaemia Research Cytogenetics Group has moved
• Notification of release of UKALL2003 Protocol Version 6
• UKALL2003 Protocol (version 6)
• Summary of Changes
• Notification of amendment form (original)
• Notification of amendment form (modified)
• MREC letter 7th July 2008
• Letter to MREC from Prof Vora
• MREC Approval
• MHRA Approval
• Patient information sheet for under 8's
• Patient information sheet for 8-14's
• Patient information sheet for older children and young adults
• Parent information sheet
• Patient consent form
• Parent consent form
• SAE reporting
• Notification of Change to Erwinase form
• Annual Report 2008
• Closure of low risk randomisation
• Information for patients and parents
• MREC letter 17th December 2010
• Notification of Closure
• Patient/parent information leaflet
• Substantial amendment form (Closure)
• Cover letter to MHRA
• Cover letter to MREC
• MREC approval for trial closure
• 6MP 10mg tablets SpC
• Interim guidelines
• MHRAclosure_approval